These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 22021706)

  • 1. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.
    Lin M; Yiu WH; Wu HJ; Chan LY; Leung JC; Au WS; Chan KW; Lai KN; Tang SC
    J Am Soc Nephrol; 2012 Jan; 23(1):86-102. PubMed ID: 22021706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
    Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U
    Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy.
    Jheng HF; Tsai PJ; Chuang YL; Shen YT; Tai TA; Chen WC; Chou CK; Ho LC; Tang MJ; Lai KT; Sung JM; Tsai YS
    Dis Model Mech; 2015 Oct; 8(10):1311-21. PubMed ID: 26398934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
    Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
    Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
    Liu P; Li F; Qiu M; He L
    Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
    Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
    Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liraglutide ameliorates inflammation and fibrosis by downregulating the TLR4/MyD88/NF-κB pathway in diabetic kidney disease.
    Huang L; Lin T; Shi M; Wu P
    Am J Physiol Regul Integr Comp Physiol; 2024 Oct; 327(4):R410-R422. PubMed ID: 39133777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy.
    Ma J; Chadban SJ; Zhao CY; Chen X; Kwan T; Panchapakesan U; Pollock CA; Wu H
    PLoS One; 2014; 9(5):e97985. PubMed ID: 24842252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria.
    Verzola D; Cappuccino L; D'Amato E; Villaggio B; Gianiorio F; Mij M; Simonato A; Viazzi F; Salvidio G; Garibotto G
    Kidney Int; 2014 Dec; 86(6):1229-43. PubMed ID: 24786705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of HMGB1 Attenuates Diabetic Nephropathy in Mice.
    Chen X; Ma J; Kwan T; Stribos EGD; Messchendorp AL; Loh YW; Wang X; Paul M; Cunningham EC; Habib M; Alexander IE; Sharland AF; Chadban SJ; Wu H
    Sci Rep; 2018 May; 8(1):8319. PubMed ID: 29844451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of toll-like receptor 2 in rat diabetic nephropathy.
    Li F; Yang N; Zhang L; Tan H; Huang B; Liang Y; Chen M; Yu X
    Am J Nephrol; 2010; 32(2):179-86. PubMed ID: 20628242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Uric Acid-Induced Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells via the TLR4/NF-kB Signaling Pathway.
    Liu H; Xiong J; He T; Xiao T; Li Y; Yu Y; Huang Y; Xu X; Huang Y; Zhang J; Zhang B; Zhao J
    Am J Nephrol; 2017; 46(4):333-342. PubMed ID: 29017152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalin suppresses renal fibrosis through microRNA-124/TLR4/NF-κB axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells.
    Zhang S; Xu L; Liang R; Yang C; Wang P
    J Physiol Biochem; 2020 Aug; 76(3):407-416. PubMed ID: 32500512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
    Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
    Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy.
    Du L; Chen Y; Shi J; Yu X; Zhou J; Wang X; Xu L; Liu J; Gao J; Gu X; Wang T; Yin Z; Li C; Yan M; Wang J; Yin X; Lu Q
    Metabolism; 2023 Jul; 144():155376. PubMed ID: 36521551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-κB pathway.
    Wang H; Huang X; Xu P; Liu X; Zhou Z; Wang F; Li J; Wang Y; Xian X; Liu G; Huang W
    Metabolism; 2021 Jun; 119():154740. PubMed ID: 33639183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes.
    Devaraj S; Tobias P; Jialal I
    Cytokine; 2011 Sep; 55(3):441-5. PubMed ID: 21498084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased macrophage activation inhibited by tacrolimus in the kidney of diabetic rats.
    Wu Y; Wang Y; Qi X; Zhang P; Zhang C; Zhang W
    Nephron Exp Nephrol; 2014; 128(1-2):46-56. PubMed ID: 25376933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapagliflozin ameliorates diabetic renal injury through suppressing the self-perpetuating cycle of inflammation mediated by HMGB1 feedback signaling in the kidney.
    Yuan Y; Sun M; Jin Z; Zheng C; Ye H; Weng H
    Eur J Pharmacol; 2023 Mar; 943():175560. PubMed ID: 36736941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.